Semaglutide, a type of GLP-1 glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonists or GLP-1 RAs), has gained awareness for its role in managing type 2 diabetes and promoting weight loss in some individuals
As we get older, our NAD+ levels drop, which can lead to fatigue, brain fog, dull skin, and poor sleep
(eClinicalMedicine, 2024), a randomized, double-blinded, two-centre, phase 2 trial of once-weekly semaglutide 1.0 mg versus placebo in 64 adults with increased fracture risk
The slimming pharmaceuticals popularized by A-listers like Oprah Winfrey and Real Housewives divas have varying effects on a persons dopamine
This category groups the reconstitution and handling materials researchers use alongside peptide compounds